Elia G, Camero M, Decaro N, Lovero A, Martella V, Tempesta M, Buonavoglia C, Crescenzo G
Department of Veterinary Medicine, University of Bari, Valenzano, Bari, Italy.
Department of Veterinary Medicine, University of Bari, Valenzano, Bari, Italy.
Res Vet Sci. 2015 Apr;99:208-11. doi: 10.1016/j.rvsc.2015.01.009. Epub 2015 Jan 21.
Caprine herpesvirus 1 (CpHV-1) infection in goats induces genital vesicular-ulcerative lesions that strictly resemble the lesions induced by herpesvirus 2 in the human host. The immunosuppressive drug Mizoribine (MIZ) was found to increase the antiviral activity of Acyclovir (ACV) against herpesvirus infections, raising interesting perspectives on new combined therapeutic strategies. In this study the anti-CpHV-1 activity in vitro of ACV alone or in combination with MIZ was characterized. When applied alone at non-toxic concentrations, ACV had a slight effect on CpHV-1 replication while in combination with MIZ a dose-dependent inhibition of the virus yield was observed with an IC50 of ACV of 28.5 µM. These findings suggest that combined therapy of ACV and MIZ is potentially exploitable in the treatment of genital infection by herpesviruses.
山羊感染1型山羊疱疹病毒(CpHV-1)会引发生殖器水疱性溃疡病变,这些病变与人类宿主感染2型疱疹病毒所引发的病变极为相似。研究发现,免疫抑制药物咪唑立宾(MIZ)可增强阿昔洛韦(ACV)对疱疹病毒感染的抗病毒活性,这为新的联合治疗策略带来了有趣的前景。在本研究中,对ACV单独使用或与MIZ联合使用时的体外抗CpHV-1活性进行了表征。当以无毒浓度单独应用时,ACV对CpHV-1复制有轻微影响,而与MIZ联合使用时,观察到对病毒产量的剂量依赖性抑制,ACV的半数抑制浓度(IC50)为28.5 μM。这些发现表明,ACV和MIZ联合治疗在治疗疱疹病毒引起的生殖器感染方面具有潜在的应用价值。